Retrieve available abstracts of 18 articles: HTML format
Single Articles
June 2025
FARAH A, Mari A AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations,
and future directions.
J Gastroenterol. 2025 Jun 18. doi: 10.1007/s00535-025-02276. PubMed
LI G, Mabe K, Haseyama M Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of
Helicobacter pylori infection.
J Gastroenterol. 2025 Jun 15. doi: 10.1007/s00535-025-02277. PubMed
March 2025
OKAMURA T, Ito A, Iwaya Y, Nagaya T, et al Long-term evaluation of Helicobacter pylori screening in school health checkups:
an 11-year study in Japan.
J Gastroenterol. 2025 Mar 7. doi: 10.1007/s00535-025-02236. PubMedAbstract available
January 2025
LI G, Togo R, Mabe K, Nishida S, et al Multistage deep learning for classification of Helicobacter pylori infection
status using endoscopic images.
J Gastroenterol. 2025 Jan 15. doi: 10.1007/s00535-024-02209. PubMedAbstract available
March 2024
KURIBAYASHI S, Nakamura F, Motegi SI, Hara K, et al Prevalence and risk factors for medication-refractory reflux esophagitis in
patients with systemic sclerosis in Japan.
J Gastroenterol. 2024;59:179-186. PubMedAbstract available
February 2024
HUANG Y, Lu H Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy
for Helicobacter pylori rescue treatment: a multicentre, randomized controlled
trial.
J Gastroenterol. 2024 Feb 14. doi: 10.1007/s00535-024-02085. PubMed
January 2024
LEECH T, Peiris M Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD)
pathogenesis.
J Gastroenterol. 2024 Jan 14. doi: 10.1007/s00535-023-02065. PubMedAbstract available
December 2023
ICHITA C, Goto T, Shimizu S Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with
upper gastrointestinal bleeding in real-world data.
J Gastroenterol. 2023 Dec 19. doi: 10.1007/s00535-023-02066. PubMed
UENO M, Fujiwara T, Tokumasu H, Mizuno M, et al Reply to "Considerations for evaluating antibiotic prophylaxis in cirrhotic
patients with upper gastrointestinal bleeding in real-world data".
J Gastroenterol. 2023 Dec 13. doi: 10.1007/s00535-023-02067. PubMed
November 2023
KAWAGUCHI T, Okamoto K, Fujimoto S, Bando M, et al Lansoprazole inhibits the development of sessile serrated lesions by inducing G1
arrest via Skp2/p27 signaling pathway.
J Gastroenterol. 2023 Nov 22. doi: 10.1007/s00535-023-02052. PubMedAbstract available
October 2023
KOTANI S, Shibagaki K, Hirahara N, Hasegawa N, et al Clinicopathologic differences of gastric neoplasms between Helicobacter
pylori-infected and -naive patients: a multicenter retrospective analysis.
J Gastroenterol. 2023 Oct 19. doi: 10.1007/s00535-023-02050. PubMedAbstract available
HAN YY, Zhou L, Hu YL, Ding XW, et al Comparison of vonoprazan-based with rabeprazole-based dual therapy for
treatment-naive patients of Helicobacter pylori infection: a prospective,
multi-center, randomized controlled study.
J Gastroenterol. 2023 Oct 1. doi: 10.1007/s00535-023-02042. PubMedAbstract available
July 2023
WATANABE K, Iijima K Risk of pneumonia associated with proton pump inhibitor use.
J Gastroenterol. 2023 Jul 16. doi: 10.1007/s00535-023-02022. PubMed
June 2023
HIRAI R, Hirai M, Otsuka M, Mitsuhashi T, et al Endoscopic evaluation by the Kyoto classification of gastritis combined with
serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects
in a population-based gastric cancer screening program.
J Gastroenterol. 2023 Jun 21. doi: 10.1007/s00535-023-02010. PubMedAbstract available
MARET-OUDA J, Panula J, Santoni G, Xie S, et al Proton pump inhibitor use and risk of pneumonia: a self-controlled case series
study.
J Gastroenterol. 2023 Jun 14. doi: 10.1007/s00535-023-02007. PubMedAbstract available
May 2023
UENO M, Fujiwara T, Tokumasu H, Mano T, et al Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding
in cirrhotic patients in Japan.
J Gastroenterol. 2023 May 12. doi: 10.1007/s00535-023-02000. PubMedAbstract available
April 2023
HUANG Y, Chen J, Ding Z, Chen X, et al Minocycline vs. tetracycline in bismuth-containing quadruple therapy for
Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial.
J Gastroenterol. 2023 Apr 12. doi: 10.1007/s00535-023-01991. PubMedAbstract available
KATO M, Hosoe N, Gotoda T, Kusano C, et al Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the
management of gastric ESD: a multicenter noninferiority randomized study.
J Gastroenterol. 2023;58:358-366. PubMedAbstract available